Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement

被引:346
作者
Phillips, CB
Barrett, JA
Losina, E
Mahomed, NN
Lingard, EA
Guadagnoli, E
Baron, JA
Harris, WH
Poss, R
Katz, JN
机构
[1] Brigham & Womens Hosp, Robert breck Brigham Multipurpose Arthrit & Muscu, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA
[4] Dartmouth Med Ctr, Dept Community & Family Med, Hanover, NH 03755 USA
关键词
D O I
10.2106/00004623-200301000-00004
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The lengths of acute hospital stays following total hip replacement have diminished substantially in recent years. As a result, a greater proportion of complications occurs following discharge. Data on the incidence trends of major complications of total hip replacement would facilitate recognition and management of these adverse events. Methods: We used Medicare claims data on beneficiaries sixty-five years and older who had had elective, primary total hip replacement for a reason other than a fracture (58,521 patients) or had had revision total hip replacement (12,956 patients) between July 1, 1995, and June 30, 1996. We calculated incidence rates of dislocation, pulmonary embolism, and deep hip infection per 10,000 person-weeks for four time-periods following the admission for the surgery (during the index hospitalization, from discharge to four weeks postoperatively, from five to thirteen weeks postoperatively, and from fourteen to twenty-six weeks postoperatively). We then used life-table methods to estimate the cumulative incidence of each complication over the first six postoperative months. Results: Of the patients who had had a primary total hip replacement, 3.9% had a dislocation, 0.9% had a pulmonary embolism, and 0.2% had a deep infection in the first twenty-six postoperative weeks. In the revision total hip replacement cohort, the proportions with dislocation, pulmonary embolism, and deep infection were 14.4%, 0.8%, and 1.1%, respectively. The rates of these adverse outcomes were highest during the index hospitalization, diminished considerably in the period from discharge to four weeks postoperatively, and continued to drop in the periods from five to thirteen and fourteen to twenty-six weeks postoperatively. Conclusions: The incidence rates of dislocation, pulmonary embolism, and deep infection are highest immediately after total hip replacement, but they continue to be elevated throughout the first three postoperative months. With the lengths of hospital stays continuing to diminish, an increasing proportion of complications will occur in outpatients. These findings provide a basis for developing strategies to prevent these complications in the postdischarge management of patients who have had elective total hip replacement. Level of Evidence: Prognostic study, Level II-1 (retrospective study). See p. 2 for complete description of levels of evidence.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 21 条
[1]   Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement [J].
Bergqvist, D ;
Benoni, G ;
Bjorgell, O ;
Fredin, H ;
Hedlundh, U ;
Nicolas, S ;
Nilsson, P ;
Nylander, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10) :696-700
[2]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[3]  
Collett D, 2014, MODELLING SURVIVAL D
[4]   Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty - Evaluation during hospitalization and three months after discharge [J].
Colwell, CW ;
Collis, DK ;
Paulson, R ;
McCutchen, JW ;
Bigler, GT ;
Lutz, S ;
Hardwick, ME .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (07) :932-940
[5]  
Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26
[6]  
DORR LD, 1998, CLIN ORTHOP RELAT R, V355, P144
[7]  
Garcia-Cimbrelo E, 1992, J Arthroplasty, V7, P149, DOI 10.1016/0883-5403(92)90008-E
[8]   Impact of cost reduction programs on short-term patient outcome andhospital cost of total knee arthroplasty [J].
Healy, WL ;
Iorio, R ;
Ko, J ;
Appleby, D ;
Lemos, DW .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (03) :348-353
[9]   Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review [J].
Hull, RD ;
Pineo, GF ;
Stein, PD ;
Mah, AF ;
MacIsaac, SM ;
Dahl, OE ;
Butcher, M ;
Brant, RF ;
Ghali, WA ;
Bergqvist, D ;
Raskob, GE .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (10) :858-869
[10]  
JOHNSON R, 1977, CLIN ORTHOP RELAT R, V127, P123